Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the browsers below.
Internet Explorer 10, Firefox, Chrome, or Safari.
All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.
Cystic Fibrosis Canada calls on remaining provinces and territories to fund Trikafta for children six and up and lift any overly-restrictive access criteria.
Read MoreCystic Fibrosis Canada calls on remaining provinces and territories to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreCystic Fibrosis Canada is calling on Quebec Health Minister to fund Trikafta now.
Read MoreTORONTO, August 3, 2022 – The Northwest Territories and Non-Insured Health Benefits (NIHB) have completed an agreement with the manufacturer of Trikafta to fund the revolutionary cystic fibrosis (CF) drug for people aged six years and older, effective July 29, 2022.
Read MoreCystic Fibrosis Canada calls on remaining provinces and territories to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreAll other provinces and territories called on to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreAll other provinces and territories called on to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreAll other provinces and territories called on to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreReview body issues milestone recommendation for the life-changing drug, removes restrictive start criterion
Read MoreCystic Fibrosis Canada calls on public and private payers to immediately fund Trikafta for all who can benefit.
Read More
